Two‐decade battle with myasthenia gravis: A breakthrough case report on the long‐term success with eculizumab and ravulizumab treatment
Key Clinical Message This unique case of generalized myasthenia gravis shows sustained stability of a patient's condition for 3 years with eculizumab/ravulizumab treatment following 16 years of refractory disease. It highlights the long‐term effectiveness of C5 inhibitors in a real‐world setting, ai...
Na minha lista:
| Hovedforfatter: | |
|---|---|
| Format: | Artigo |
| Sprog: | Inglês |
| Udgivet: |
Wiley
2024-11-01
|
| Serier: | Clinical Case Reports |
| Fag: | |
| Online adgang: | https://doi.org/10.1002/ccr3.9547 |
| Tags: |
Ingen Tags, Vær først til at tagge denne postø!
|